Skip to main content
. 2019 Dec 30;9:20271. doi: 10.1038/s41598-019-56854-5

Figure 6.

Figure 6

Effect of valproic acid (VPA) and hydralazine on DNMT and HDAC protein levels in mammary tumors. Treatment with VPA/hydralazine decreased the expression of (a) DNMT3A (p = 0.046 for treatment). No changes in the levels of (b) DNMT1 or (c) HDAC1 were seen. P-values obtained in Holm-Sidak post-hoc test are shown in figure. Means and SEM of 4–7 tumors per group are shown.